Clinical relevance of KRAS-mutated sub-clones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy Pierre Laurent-Puig, Deniz Pekin, Corinne Normand, Steve K. Kotsopoulos, Philippe Nizard, Karla Perez Toralla, Rachel Rowe, Jeff Olson, Pree
Our ThunderBolts™ Cancer Panel is quickly setting a new performance standard for researching important cancer-bearing somatic mutations. The new next-generation sequencing panel offers several industry breakthroughs in sequence coverage and uniformity, allelic sensitivity, sample flex
Senior executive brings experience commercializing products in the molecular pathology and cancer markets at Roche Diagnostics, Life Technologies, Gen-Probe, and Sequenom BILLERICA, Mass. — September 22, 2014 — RainDance Technologies, Inc., a genomics tools company simplifying the an
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.